Abstract
BACKGROUND: Alloimmunization after exposure to donor red cell (RBC) antigens remains a major clinical problem in transfusion medicine, particularly for patients in need of chronic transfusions. The identification of T regulatory cells (Tregs) among the CD4+CD25+ T cell subset as key regulators of peripheral tolerance in mice as well as humans has opened an exciting era in the prevention and treatment of autoimmune disease and for improving organ transplantation. However, their potential in inducing transfusion tolerance so as to prevent or blunt the alloimmune response to allogeneic red cells has not been explored.
METHODS AND RESULTS: To determine a role for Tregs in control of alloimmune responses, we have manipulated Treg numbers by either depletion of CD25-expressing cells or transfer of purified CD4+CD25+ Treg cells in two different mouse models of RBC immunization. Using a mouse model of RBC immunization in which weekly injection of rat RBCs results in the development of antibodies to rat red cells, we previously showed that depletion with anti-CD25 increased the antibody response to rat RBCs (
CONCLUSIONS: Altogether, our results demonstrate that Tregs control transfusion-associated alloantibody responses. Our data indicate that Treg immunotherapy by enhancement of Treg function may be exploited for future therapeutic approaches for suppressing transfusion immunization events.
Disclosure: No relevant conflicts of interest to declare.
Author notes
Corresponding author
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal